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Totally implantable venous access devices (TIVAD) are used widely in the management of cystic fibrosis (CF) [Standards of Care: Standards
for the clinical care of children and adults with cystic fibrosis in the UK. The Cystic Fibrosis Trust's Clinical Standards and Accreditation Group.
Cystic Fibrosis Trust, London, UK, 2001]. They have been shown to be safe and advantageous in the long term administration of intravenous
antibiotics [A-Rahman A, Spencer D. Totally implantable vascular access devices for cystic fibrosis. Cochrane Database Syst Rev 2003(3)].
However, TIVADs are not without short and long term complications including infections, thrombosis and mechanical failure [Munck A,
Malbezin S, Bloch J. Follow up of 452 totally implantable vascular devices in cystic fibrosis patients. Eur Respir J 2004;23:430–4; Aitkin ML,
Tonelli ML. Complications of indwelling catheters in cystic fibrosis: a 10-year review. Chest 2000;118:1598–602; Deerojanawong J, Sawyer SM,
Fink AM, Stokes KB, Robertson CF. Totally implantable venous access devices in children with cystic fibrosis. Thorax 1998;53:285–89; Rodgers
HC, Liddle K, Nixon SJ, Innes JA, Greening AP. Totally implantable venous access devices in cystic fibrosis: complications and patients'
opinions. Eur Respir J 1998;12:217–20; Yung B, Campbell IA, Elborn JS, Harvey JS, Shale DJ. Totally implantable venous access devices in
adult patients with cystic fibrosis. Respir Med 1996;90:353–56; Kariyawasam HH, Pepper JR, Hodson ME, Geddes DM. Experience of totally
implantable venous access devices (TIVAds) in adults with cystic fibrosis over a 13-year period. Respir Med 2000;94:1161–5]. Patients should be
counselled prior to TIVAD insertion regarding the risks and instructed on post-operative care of the device to minimise the risks. However it is not
routine practice to advise on seating position within the car in relationship to the seatbelt placement over the anterior chest wall. Line failure due to
direct pressure from a seatbelt worn to prevent injury in the sudden deceleration involved during a motor vehicle accident (MVA) has not been
described previously in the CF literature We report the case of an 8 year old child who fractured her Vascuport® line secondary to seatbelt trauma
following a road traffic accident (RTA). Children and adults with CF should be advised to sit in the car on the side that places the shoulder strap of
the seatbelt on the opposite side to the TIVAD line.
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Our patient was diagnosed with CF at the age of 14 weeks
after a history of poor growth and a bronchiolitic illness,
complicated by a staphylococcal pneumonia. At the age of
5 years she had a paediatric Vascuport® (Simiplant, Vygon)Abbreviations: TIVAD, Totally implantable venous access devices; CF,
Cystic fibrosis; MVA, Motor vehicle accident; RTA, Road traffic accident.
⁎ Corresponding author. Tel.: +44 8451558174; fax: +44 8451558230.
E-mail address: salim.ghayyda@doctors.org.uk (S.N.S. Ghayyda).
1569-1993/$ - see front matter © 2008 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2008.03.002inserted through the right internal jugular vein, tunnelled
subcutaneously through the right anterior chest wall. This was
to provide routine intravenous antibiotics for Pseudomonas
aeruginosa lung colonisation and to treat acute exacerbations as
necessary. The line functioned very well and there were no
issues with antibiotic administration for 2 years. At the age of
7 years she was a passenger involved in a road traffic accident,
resulting in the sudden deceleration of the car. She was wearing
a seatbelt with the shoulder strap overlying the line on the side
the Vascuport® had been placed. She sustained no significant
injury at the time of the crash. Several days later, on routined by Elsevier B.V. All rights reserved.
Fig. 1.
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her neck and upper chest wall. A linogram demonstrated
leakage in two sites, compatible with the edges of the shoulder
strap of the seatbelt overlying the anterior chest wall and line
(Fig. 1). There was no evidence of line infection or thrombosis.
The line had been flushed one month previously without
problem. The Vascuport and line were surgically removed and
replaced, during the same procedure, with another TIVAD
placed on the opposite side of the chest with the line in the left
sided internal jugular vein with subcutaneous tunnelling to the
left side of the chest.
Post-operatively she developed signs of superior vena caval
obstruction with swelling and pain of her upper chest wall and
face. A venogram confirmed bilateral brachiocephalic vein
obstruction with fresh clot in the left subclavian vein. Sub-
sequent cardiac catherisation demonstrated fresh thrombus in
the SVC and a tight stenosis of the SVC brachiocephalic
confluence requiring stent insertion. She underwent removal of
the second TIVAD and was commenced on anticoagulant
therapy. She has remained on long term warfarin therapy and
requires regular coagulation checks. The family have been
seeking monetary compensation from the driver of the other car
involved in the motor vehicle accident through the British
legal system for the last 4 years, to date without satisfactory
resolution.
2. Discussion
The use of TIVADs has become standard practice in the
management of CF patients [1]. These devices are typically a
safe and effective way to administer intravenous medications
negating the requirement for repeated venous cannulation [2].
However, it is recognised that these lines can be associated
with a number of complications. The most commonly seencomplications seen in the CF population are mechanical,
thrombosis, infection and thrombo-embolisation [3–8]. Fracture
of the TIVAD line has been described in the non-CF literature
[9–11]. Pinch-off syndrome where the line is compressed
between the clavicle and the first rib is one cause of tearing or
trans-section of the line [9]. Another case report describes
fracture of the TIVAD line in an adult male from carrying a
refrigerator on the homo-lateral shoulder to the TIVAD [10]. A
final case report describes a line fracture of a central venous
catheter without clear causation [11]. Interference with the
comfortable wearing of seatbelts has been described in 27% of a
cohort of 30 adult cystic fibrosis patients with TIVADs in place
[6]. However, no case of line fracture from any cause has been
described in the CF literature previously.
Up until this patient presented with the complication
described, no advice regarding wearing seatbelts had been
given in our unit. However, we now routinely advise that
patients with TIVADs placed with the line in the veins above the
heart, wear the shoulder strap of their seatbelt on the opposite
side to the TIVAD placement. This will hopefully reduce the
risk of traumatic line rupture should the seatbelt be required in a
road traffic accident.
Although patients may appear unharmed following a RTA,
there is a risk of seatbelt-related TIVAD damage. Patients
complaining of pain on accessing the device should be
investigated appropriately for damage to the line.
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